Friday, 18 April 2025
  
Login

Australia's most trusted
source of pharma news

Friday, 18 April 2025
News

Trump blow hurts pharma stocks

Posted 10 April 2025 PM

There was a swift stock market fallout from Donald Trump's announcement that tariffs on pharmaceuticals were coming "very" soon - with most Big Pharmas hit by an immediate dip in share price.

Yesterday, US companies Pfizer, MSD, Gilead and Lilly saw their share prices dip between 1.5 and three per cent while European pharmas slipped too, with Novo Nordisk stock down by about two per cent, Sanofi down by three and AstraZeneca and GSK, dipping four per cent.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (13)

Clinical & Medical, R&D (4)

Regulatory, Pharmacovigilance & QA (7)

Other (16)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.